Pharmacy Deserts: An Update for 2026
Summary Pharmacy deserts continue to be a major healthcare issue in the U.S. About 48 million Americans currently live in […]
Why Oncology Medicine Spending is on the Rise
Summary Oncology medicine spending is expected to grow by 75% over the next five years due to certain factors: Growing
2025 biosimilar approvals
Summary The Food and Drug Administration (FDA) approved 18 biosimilars in 2025. February was the busiest month for approvals with
News: VytlOne celebrates 100 years
Summary VytlOne marks its 100th anniversary as the nation’s only independent, fully integrated total pharmacy solutions partner. 100 years of
2025 drug approvals, breakthroughs, and trends
Summary The Food and Drug Administration (FDA) approved 46 novel drugs in 2025, four fewer than the amount approved in
Drug Shortages: Q4 Update
Summary Many drug shortages are long-lasting, with the majority carrying over year to year and the average duration exceeding four
News: VytlOne Releases 2nd Annual Healthcare Leader Report
Summary 2nd annual survey featuring responses from 100 health care and pharmacy leaders shows increased urgency to improve community pharmacy
Pharmacy Deserts in the United States: A Continuing Crisis
Summary Nearly 48 million Americans now live in pharmacy deserts, areas where access to local pharmacies is limited, up from
How do specialty clinical programs transform patient experience and prepare pharmacies for the future?
Summary Health system and health center pharmacies face complex challenges in delivering high-quality care and meeting accreditation, payer, and medication
What is copay abandonment?
Summary Copay abandonment occurs when patients do not pick up their prescribed medications with rates increasing sharply as drug costs